Risk factors for hematoma in patients undergoing cardiac device procedures: A WRAP-IT trial analysis

BACKGROUND: Implant site hematoma is a known complication of cardiac device procedures and can lead to major consequences. OBJECTIVES: To evaluate risk factors for hematoma and further understand the relationship between anticoagulant (AC), antiplatelet (AP) use, and hematoma development. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarakji, Khaldoun G., Korantzopoulos, Panagiotis, Philippon, Francois, Biffi, Mauro, Mittal, Suneet, Poole, Jeanne E., Kennergren, Charles, Lexcen, Daniel R., Lande, Jeff D., Hilleren, Gregory, Seshadri, Swathi, Wilkoff, Bruce L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626743/
https://www.ncbi.nlm.nih.gov/pubmed/36340491
http://dx.doi.org/10.1016/j.hroo.2022.05.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626743/
https://www.ncbi.nlm.nih.gov/pubmed/36340491
http://dx.doi.org/10.1016/j.hroo.2022.05.012

Ejemplares similares